Kidney Transplantation: Challenging the Future

Indexed in: Web of Science and Scopus, Book Citation Index, Science Edition.

Kidney transplantation is worldwide considered the best replacement therapy in patients with end-stage renal disease. However, although impressive improvements in surgical techniques and in the ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Clinical Tolerance in Kidney Transplantation

Pp. 370-377 (8)

DOI: 10.2174/978160805144111201010370

Author(s): Tatsuo Kawai, A. Benedict Cosimi

Abstract

Induction of donor specific tolerance has been the ultimate goal in organ transplantation. Recent application of approaches to the induction of allograft tolerance in human kidney transplant recipients has been based upon preclinical studies in nonhuman primates, including 1) profound T cell depletion by powerful anti-T cell antibodies, 2) use of total lymphoid irradiation, 3) costimulatory blockade, 4) infusion of anergic cells 5) donor bone marrow (DBM) infusion without anticipation of engraftment and 6) DBM transplantation leading to Mixed Chimerism. Mixed Chimerism following DBM transplantation has to date been the most successful approach for induction of renal allograft tolerance in clinical kidney transplantation trials.

Keywords:

Tolerance, Mixed Chimerism, Kidney Transplantation, Immunosuppression, Central Tolerance, Peripheral Tolerance, Prope Tolerance, Costimulatory Blockade, T-Cells Depletion, Blood Marrow Infusion.